[1] |
Orth M,Schapira AH.Mitochondrial involvement in Parkinson′s disease[J].Neurochem Int,2002,40(6):533-541.
|
[2] |
Kalia LV,Lang AE.Parkinson′s disease[J].Lancet,2015,386(9996):896-912.
|
[3] |
Michael T Hayes.Parkinson′s Disease and Parkinsonism[J].Am J Med,2019,132(7):802-807.
|
[4] |
Puspita L,Chung SY,Shim JW.Oxidative stress and cellular pathologies in Parkinson′s disease[J].Mol Brain,2017,10(1):53.
|
[5] |
Trist BG,Hare DJ,Double KL.Oxidative stress in the aging substantia nigra and the etiology of Parkinson′s disease[J].Aging Cell,2019,18(6):e13031.
|
[6] |
Joseph SK,Booth DM,Young MP,et al.Redox regulation of ER and mitochondrial Ca2+signaling in cell survival and death[J].Cell Calcium,2019,79:89-97.
|
[7] |
Ki YW,Lee JE,Park JH,et al.Reactive oxygen species and mitogen-activated protein kinase induce apoptotic death of SH-SY5Y cells in response to fipronil[J].Toxicol Lett,2012,211(1):18-28.
|
[8] |
Bertero E,Maack C.Calcium Signaling and Reactive Oxygen Species in Mitochondria[J].Circ Res,2018,122(10):1460-1478.
|
[11] |
Banerjee J,Khanna S,Bhattacharya A.MicroRNA Regulation of Oxidative Stress[J].Oxid Med Cell Longev,2017,2017:2872156.
|
[14] |
Bose A,Beal MF.Mitochondrial dysfunction in Parkinson′s disease[J].J Neurochem,2016,139(Suppl 1):216-231.
|
[9] |
Gao T,Shi L,Zhang T,et al.Cross Talk between Calcium and Reactive Oxygen Species Regulates Hyphal Branching and Ganoderic Acid Biosynthesis in Ganoderma lucidum under Copper Stress[J].Appl Environ Microbiol,2018,84(13):e00438-18.
|
[10] |
Ma Q.Transcriptional responses to oxidative stress:pathological and toxicological implications[J].Pharmacol Ther,2010,125(3):376-393.
|
[12] |
Vieira HL,Alves PM,Vercelli A.Modulation of neuronal stem cell differentiation by hypoxia and reactive oxygen species[J].Prog Neurobiol,2011,93(3):444-455.
|
[13] |
Maffezzini C,Calvo-Garrido J,Wredenberg A,et al.Metabolic regulation of neurodifferentiation in the adult brain[J].Cell Mol Life Sci,2020,77(13):2483-2496.
|
[15] |
Delamarre A,Meissner WG.Epidemiology,environmental risk factors and genetics of Parkinson′s disease[J].Presse Med,2017,46(2 Pt 1):175-181.
|
[16] |
Singh A,Kukreti R,Saso L,et al.Oxidative Stress:A Key Modulator in Neurodegenerative Diseases[J].Molecules,2019,24(8):1583.
|
[17] |
Liang S,Figtree G,Aiqun M,et al.GAPDH-knockdown reduce rotenone-induced H9C2 cells death via autophagy and anti-oxidative stress pathway[J].Toxicol Lett,2015,234(3):162-171.
|
[18] |
Wu T,Fang X,Xu J,et al.Synergistic Effects of Ginkgolide B and Protocatechuic Acid on the Treatment of Parkinson′s Disease[J].Molecules,2020,25(17):3976.
|
[19] |
Kuang S,Yang L,Rao Z,et al.Effects of Ginkgo Biloba Extract on A53T α-Synuclein Transgenic Mouse Models of Parkinson′s Disease[J].Can J Neurol Sci,2018,45(2):182-187.
|
[20] |
Joseph-Bravo P,Jaimes-Hoy L,Uribe RM,et al.60 years of neuroendoccrinology:TRH,the first hypophysiotropic releasing hormone isolated:control of the pituitary-thyroid axis[J].J Endocrinol,2015,226(2):T85-T100.
|
[21] |
张萍,肖斌,蔡新勇,等.银杏叶制剂在帕金森病患者中的应用效果[J].中国当代医药,2019,26(28):64-67.
|